NDC 0074-1824 - Novocain

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0074-1824
Package NDCs from labels: 0074-1824-30
Manufacturer: Hospira, Inc.
Effective date: 2007-04-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-04-16	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0074-1824-30	Novocain	1 in 1 CARTON	INJECTION, SOLUTION	1		1
0074-1824-30	Novocain	100 in 1 CASE	INJECTION, SOLUTION	100		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0074-1824	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1	2 package rows	20070426_C80C810A-60E0-49BD-139C-95AEC3A286FC.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Chlorobutanol	INACTIVE INGREDIENT	HM4YQM8WRC	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 13 · 253 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
sodium chloride	SODIUM CHLORIDE	Medefil, Inc.	d1468c0f-dd4f-4d38-a84c-c1d110303965	2026-02-26	Warnings, Adverse reactions	Name fallback brand name: sodium chloride
VinCRIStine Sulfate	VINCRISTINE SULFATE	Hospira, Inc.	b22e4c8e-dbe1-4d4b-a026-e1812974071c	2026-02-17	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Magnesium Sulfate	MAGNESIUM SULFATE	Hospira, Inc.	e175d329-315f-4f3b-bb4c-06ad4e042967	2026-02-12	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Hydromorphone Hydrochloride	HYDROMORPHONE HYDROCHLORIDE	Hospira, Inc.	f9ca2ef5-46d8-475a-a26e-f7c8becd6db7	2026-02-04	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Calcium Chloride	CALCIUM CHLORIDE	Hospira, Inc.	c4c65e48-85f8-4dcf-6281-06e40959cc79	2026-02-02	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Nephron Pharmaceuticals Corporation	a4edf2d5-a9ff-30d4-e053-2995a90a5650	2026-01-26	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	ProPharma Distribution	48d73434-e65b-dc98-e063-6294a90affa2	2026-01-20	Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	d98bf9f7-30ec-4927-a577-cabad192cb18	2026-01-19	Warnings, Adverse reactions	Name fallback brand name: Sodium chloride
Sodium chloride	SODIUM CHLORIDE	BECTON DICKINSON AND COMPANY	d39b7307-df67-4e68-acb0-2eda5dc61215	2026-01-07	Warnings, Adverse reactions	Name fallback brand name: Sodium chloride
Buprenorphine Hydrochloride	BUPRENORPHINE HYDROCHLORIDE	Hospira, Inc.	23aa1bb3-cecf-4e62-29bb-48488bb66fc3	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Morphine Sulfate	MORPHINE SULFATE	Hospira, Inc.	be420e8b-bcb0-49b5-bb4d-1df8b9959809	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Morphine Sulfate	MORPHINE SULFATE	Hospira, Inc.	ee8057d1-ed12-4e18-9efa-d83504abf612	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Hydromorphone Hydrochloride	HYDROMORPHONE HYDROCHLORIDE	Hospira, Inc.	e9c9ef18-7dfc-4322-b2fc-29b934c30f8b	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Nalbuphine Hydrochloride	NALBUPHINE HYDROCHLORIDE	Hospira, Inc.	6025e8d4-5083-4c3a-58a0-050e7b0b6150	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
VinCRIStine Sulfate	VINCRISTINE SULFATE	Hospira, Inc.	49596de6-ab18-49d1-9e5b-30968fc21c36	2025-12-30	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	ProPharma Distribution	3f79fb8b-d0e8-db2a-e063-6394a90ac136	2025-12-18	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	SOLA Pharmaceuticals, LLC	4d0bfd28-460a-48ba-bd17-cf75e56d62f4	2025-12-09	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Regadenoson	REGADENOSON	Hospira, Inc.	0e3f080d-b1fb-47ed-8cd3-90a4206fa704	2025-12-08	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ondansetron	ONDANSETRON	Hospira, Inc.	e0862c02-781f-4b10-ae50-9c9c4ca26f6d	2025-12-01	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Metronidazole	METRONIDAZOLE	Hospira, Inc.	49360d6f-c8b3-420e-af75-154cf7b05255	2025-11-19	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.